Pre-onset risk characteristics for mania among young people at clinical high risk for psychosis

Schizophrenia Research

Volumn 192, Issue , 2018, Pages 345-350

  Ratheesh, Aswin ^a,b   Cotton, Susan M ^a,b   Davey, Christopher G ^a,b   Lin, Ashleigh ^c   Wood, Stephen ^a,b,d   Yuen, Hok Pan ^a,b   Bechdolf, Andreas ^e   McGorry, Patrick D ^a,b   Yung, Alison ^f   Berk, Michael ^a,g,h   Nelson, Barnaby ^a,b  

^a THE NATIONAL CENTRE OF EXCELLENCE IN YOUTH MENTAL HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f UNIVERSITY OF MANCHESTER   (United Kingdom)

^g FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^h DEAKIN UNIVERSITY   (Australia)

Author keywords

Antidepressants; At risk; Bipolar disorder; Mania; Psychosis; Subthreshold

Indexed keywords

ANTIDEPRESSANT AGENT;

ADOLESCENT; ADULT; AGE; ARTICLE; BIPOLAR I DISORDER; CASE CONTROL STUDY; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG USE; FEMALE; GENDER; HIGH RISK POPULATION; HUMAN; MALE; MANIA; MINOR DEPRESSION; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PSYCHOSIS; RISK FACTOR; SCHIZOAFFECTIVE PSYCHOSIS; STRUCTURED INTERVIEW; BIPOLAR DISORDER; COMPLICATION; PRODROMAL SYMPTOM; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; BIPOLAR DISORDER; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HUMANS; MALE; PRODROMAL SYMPTOMS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; RISK FACTORS; YOUNG ADULT;

EID: 85026366102     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2017.04.036     Document Type: Article

References (52)

1. Allott, K., Chanen, A., Yuen, H.P., Attrition bias in longitudinal research involving adolescent psychiatric outpatients. J. Nerv. Ment. Dis. 194:12 (2006), 958–961.
2. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders. fourth ed., 1994 (Washington, D.C.).
3. Andreasen, N.C., Scale for the Assessment of Negative Symptoms (SANS) University of Iowa. 1984 (Iowa City).
4. Bechdolf, A., Nelson, B., Cotton, S.M., Chanen, A., Thompson, A., Kettle, J., Conus, P., Amminger, G.P., Yung, A.R., Berk, M., McGorry, P.D., A preliminary evaluation of the validity of at-risk criteria for bipolar disorders in help-seeking adolescents and young adults. J. Affect. Disord. 127:1–3 (2010), 316–320.
5. Bechdolf, A., Ratheesh, A., Wood, S.J., Tecic, T., Conus, P., Nelson, B., Cotton, S.M., Chanen, A.M., Amminger, G.P., Ruhrmann, S., Schultze-Lutter, F., Klosterkotter, J., Fusar Poli, P., Yung, A.R., Berk, M., McGorry, P.D., Rationale and first results of developing at-risk (prodromal) criteria for bipolar disorder. Curr. Pharm. Des. 18:4 (2012), 358–375.
6. Bechdolf, A., Ratheesh, A., Cotton, S.M., Nelson, B., Chanen, A., Betts, J., Bingmann, T., Yung, A., Berk, M., McGorry, P., The Predictive Validity of Bipolar At-risk (Prodromal) Criteria in Help Seeking Adolescents and Young Adults: A Prospective Study Bipolar Disorders. 2014.
7. Berger, G.E., Wood, S.J., Ross, M., Hamer, C.A., Wellard, R.M., Pell, G., Phillips, L., Nelson, B., Amminger, G.P., Yung, A.R., Jackson, G., Velakoulis, D., Pantelis, C., Manji, H., McGorry, P.D., Neuroprotective effects of low-dose lithium in individuals at ultra-high risk for psychosis. A longitudinal MRI/MRS study. Curr. Pharm. Des. 18:4 (2012), 570–575.
8. Berk, M., Conus, P., Lucas, N., Hallam, K., Malhi, G.S., Dodd, S., Yatham, L.N., Yung, A., McGorry, P., Setting the stage: from prodrome to treatment resistance in bipolar disorder. Bipolar Disord. 9:7 (2007), 671–678.
9. Berk, M., Hallam, K., Lucas, N., Hasty, M., McNeil, C.A., Conus, P., Kader, L., McGorry, P.D., Early intervention in bipolar disorders: opportunities and pitfalls. Med. J. Aust. 187:7 Suppl (2007), S11–S14.
10. Birmaher, B., Axelson, D., Strober, M., Gill, M.K., Valeri, S., Chiappetta, L., Ryan, N., Leonard, H., Hunt, J., Iyengar, S., Keller, M., Clinical course of children and adolescents with bipolar spectrum disorders. Arch. Gen. Psychiatry 63:2 (2006), 175–183.
11. Clementz, B.A., Sweeney, J.A., Hamm, J.P., Ivleva, E.I., Ethridge, L.E., Pearlson, G.D., Keshavan, M.S., Tamminga, C.A., Identification of distinct psychosis biotypes using brain-based biomarkers. Am. J. Psychiatry 173:4 (2016), 373–384.
12. Correll, C.U., Smith, C.W., Auther, A.M., McLaughlin, D., Shah, M., Foley, C., Olsen, R., Lencz, T., Kane, J.M., Cornblatt, B.A., Predictors of remission, schizophrenia, and bipolar disorder in adolescents with brief psychotic disorder or psychotic disorder not otherwise specified considered at very high risk for schizophrenia. J. Child Adolesc. Psychopharmacol. 18:5 (2008), 475–490.
13. Correll, C.U., Olvet, D.M., Auther, A.M., Hauser, M., Kishimoto, T., Carrion, R.E., Snyder, S., Cornblatt, B.A., The bipolar prodrome symptom interview and scale-prospective (BPSS-P): description and validation in a psychiatric sample and healthy controls. Bipolar Disord. 16:5 (2014), 505–522.
14. Duffy, A., Toward a comprehensive clinical staging model for bipolar disorder: integrating the evidence. Can. J. Psychiatr. 59:12 (2014), 659–666.
15. Duffy, A., Alda, M., Hajek, T., Grof, P., Early course of bipolar disorder in high-risk offspring: prospective study. Br. J. Psychiatry J. Ment. Sci. 195:5 (2009), 457–458.
16. Endicott, J., Spitzer, R.L., Fleiss, J.L., Cohen, J., The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch. Gen. Psychiatry 33:6 (1976), 766–771.
17. Fiedorowicz, J.G., Endicott, J., Leon, A.C., Solomon, D.A., Keller, M.B., Coryell, W.H., Subthreshold hypomanic symptoms in progression from unipolar major depression to bipolar disorder. Am. J. Psychiatry 168:1 (2011), 40–48.
18. First, M.B., Spitzer, R.L., Gibbon, M., Structured Clinical Interview for DSM-IV Axis I Disorders-Research Version, Patient Edition (SCID-I/P). 1997, Biometrics Research Department, New York State Psychiatric Institute, New York, NY.
19. Fusar-Poli, P., Bechdolf, A., Taylor, M.J., Bonoldi, I., Carpenter, W.T., Yung, A.R., McGuire, P., At risk for schizophrenic or affective psychoses? A meta-analysis of DSM/ICD diagnostic outcomes in individuals at high clinical risk. Schizophr. Bull. 39:4 (2013), 923–932.
20. Gignac, A., McGirr, A., Lam, R.W., Yatham, L.N., Recovery and recurrence following a first episode of mania: a systematic review and meta-analysis of prospectively characterized cohorts. J. Clin. Psychiatry 76:9 (2015), 1241–1248.
21. Gilman, S.E., Dupuy, J.M., Perlis, R.H., Risks for the transition from major depressive disorder to bipolar disorder in the National Epidemiologic Survey on Alcohol and Related Conditions. J. Clin. Psychiatry 73:6 (2012), 829–836.
22. Hamilton, M., A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23 (1960), 56–62.
23. Heinrichs, D.W., Hanlon, T.E., Carpenter, W.T. Jr., The quality of life scale: an instrument for rating the schizophrenic deficit syndrome. Schizophr. Bull. 10:3 (1984), 388–398.
24. Henquet, C., Krabbendam, L., de Graaf, R., ten Have, M., van Os, J., Cannabis use and expression of mania in the general population. J. Affect. Disord. 95:1–3 (2006), 103–110.
25. Holma, K.M., Melartin, T.K., Holma, I.A., Isometsa, E.T., Predictors for switch from unipolar major depressive disorder to bipolar disorder type I or II: a 5-year prospective study. J. Clin. Psychiatry 69:8 (2008), 1267–1275.
26. Levy, B., Medina, A.M., Weiss, R.D., Cognitive and psychosocial functioning in bipolar disorder with and without psychosis during early remission from an acute mood episode: a comparative longitudinal study. Compr. Psychiatry 54:6 (2013), 618–626.
27. Lewandowski, K.E., Cohen, B.M., Ongur, D., Evolution of neuropsychological dysfunction during the course of schizophrenia and bipolar disorder. Psychol. Med. 41:2 (2011), 225–241.
28. Lin, A., Wood, S.J., Nelson, B., Beavan, A., McGorry, P., Yung, A.R., Outcomes of nontransitioned cases in a sample at ultra-high risk for psychosis. Am. J. Psychiatry 172:3 (2015), 249–258.
29. Maxwell, M.E., Family interview for genetic studies: a manual for FIGS. Clinical neurogenetic Branch, Intramural Research Program; NIMH, 1992.
30. McGorry, P.D., Yung, A.R., Phillips, L.J., Yuen, H.P., Francey, S., Cosgrave, E.M., Germano, D., Bravin, J., McDonald, T., Blair, A., Adlard, S., Jackson, H., Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch. Gen. Psychiatry 59:10 (2002), 921–928.
31. Nelson, B., Yuen, H.P., Wood, S.J., Lin, A., Spiliotacopoulos, D., Bruxner, A., Broussard, C., Simmons, M., Foley, D.L., Brewer, W.J., Francey, S.M., Amminger, G.P., Thompson, A., McGorry, P.D., Yung, A.R., Long-term follow-up of a group at ultra-high risk (“prodromal”) for psychosis: the PACE 400 study. JAMA Psychiat. 70:8 (2013), 793–802.
32. Olvet, D.M., Stearns, W.H., McLaughlin, D., Auther, A.M., Correll, C.U., Cornblatt, B.A., Comparing clinical and neurocognitive features of the schizophrenia prodrome to the bipolar prodrome. Schizophr. Res. 123:1 (2010), 59–63.
33. Overall, J.E., Gorham, D.R., The brief psychiatric rating scale. Psychol. Rep. 10 (1962), 799–812.
34. Pallant, J., SPSS Survival Manual: A Step by Step Guide to Data Analysis Using SPSS for Windows Version 15. third ed., 2007, Open University Press Milton Keynes, UK.
35. Phillips, L.J., Curry, C., Yung, A.R., Yuen, H.P., Adlard, S., McGorry, P.D., Cannabis use is not associated with the development of psychosis in an ‘ultra’ high-risk group. Aust. N. Z. J. Psychiatry 36:6 (2002), 800–806.
36. Phillips, L.J., Nelson, B., Yuen, H.P., Francey, S.M., Simmons, M., Stanford, C., Ross, M., Kelly, D., Baker, K., Conus, P., Amminger, P., Trumpler, F., Yun, Y., Lim, M., McNab, C., Yung, A.R., McGorry, P.D., Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: study design and baseline characteristics. Aust. N. Z. J. Psychiatry 43:9 (2009), 818–829.
37. Regier, D.A., Narrow, W.E., Clarke, D.E., Kraemer, H.C., Kuramoto, S.J., Kuhl, E.A., Kupfer, D.J., DSM-5 field trials in the United States and Canada, part II: test-retest reliability of selected categorical diagnoses. Am. J. Psychiatry 170:1 (2013), 59–70.
38. Salokangas, R.K.R., Ruhrmann, S., Graf Von Reventlow, H., Heinimaa, M., Svirskis, T., Luutonen, S., Juckel, G., Linszen, D., Dingemans, P., Birchwood, M., Patterson, P., Klosterkotter, J., Axis i diagnoses and transition to psychosis in clinical high-risk patients. Eur. Psychiatry, 27, 2012.
39. Scott, J., Leboyer, M., Hickie, I., Berk, M., Kapczinski, F., Frank, E., Kupfer, D., McGorry, P., Clinical staging in psychiatry: a cross-cutting model of diagnosis with heuristic and practical value. Br. J. Psychiatry 202 (2013), 243–245.
40. Smoller, J.W., Disorders and borders: psychiatric genetics and nosology. Am. J. Med. Genet. B Neuropsychiatr. Genet. 162:7 (2013), 559–578.
41. Strober, M., Carlson, G., Bipolar illness in adolescents with major depression: clinical, genetic, and psychopharmacologic predictors in a three- to four-year prospective follow-up investigation. Arch. Gen. Psychiatry 39:5 (1982), 549–555.
42. Taiminen, T., Ranta, K., Karlsson, H., Lauerma, H., Leinonen, K.M., Wallenius, E., Kaljonen, A., Salokangas, R.K., Comparison of clinical and best-estimate research DSM-IV diagnoses in a Finnish sample of first-admission psychosis and severe affective disorder. Nord. J. Psychiatry 55:2 (2001), 107–111.
43. Thompson, K.N., Phillips, L.J., Komesaroff, P., Yuen, H.P., Wood, S.J., Pantelis, C., Velakoulis, D., Yung, A.R., McGorry, P.D., Stress and HPA-axis functioning in young people at ultra-high risk for psychosis. J. Psychiatr. Res. 41:7 (2007), 561–569.
44. Thompson, A., Nelson, B., Yung, A., Predictive validity of clinical variables in the “at risk” for psychosis population: international comparison with results from the North American Prodrome Longitudinal Study. Schizophr. Res. 126:1–3 (2011), 51–57.
45. Tijssen, M.J., van Os, J., Wittchen, H.U., Lieb, R., Beesdo, K., Mengelers, R., Wichers, M., Prediction of transition from common adolescent bipolar experiences to bipolar disorder: 10-year study. Br. J. Psychiatry J. Ment. Sci. 196:2 (2010), 102–108.
46. Tondo, L., Vazquez, G., Baldessarini, R.J., Mania associated with antidepressant treatment: comprehensive meta-analytic review. Acta Psychiatr. Scand. 121:6 (2010), 404–414.
47. Webb, J.R., Addington, J., Perkins, D.O., Bearden, C.E., Cadenhead, K.S., Cannon, T.D., Cornblatt, B.A., Heinssen, R.K., Seidman, L.J., Tarbox, S.I., Tsuang, M.T., Walker, E.F., McGlashan, T.H., Woods, S.W., Specificity of incident diagnostic outcomes in patients at clinical high risk for psychosis. Schizophr. Bull. 41:5 (2015), 1066–1075.
48. Yung, A.R., Phillips, L.J., Yuen, H.P., Francey, S.M., McFarlane, C.A., Hallgren, M., McGorry, P.D., Psychosis prediction: 12-month follow up of a high-risk (“prodromal”) group. Schizophr. Res. 60:1 (2003), 21–32.
49. Yung, A.R., Phillips, L.J., Yuen, H.P., McGorry, P.D., Risk factors for psychosis in an ultra-high-risk group: psychopathology and clinical features. Schizophr. Res. 67:2–3 (2004), 131–142.
50. Yung, A.R., Yuen, H.P., McGorry, P.D., Phillips, L.J., Kelly, D., Dell'Olio, M., Francey, S.M., Cosgrave, E.M., Killackey, E., Stanford, C., Godfrey, K., Buckby, J., Mapping the onset of psychosis: the comprehensive assessment of at-risk mental states. Aust. N. Z. J. Psychiatry 39:11 − 12 (2005), 964–971.
51. Yung, A.R., McGorry, P.D., Francey, S.M., Nelson, B., Baker, K., Phillips, L.J., Berger, G., Amminger, G.P., PACE: a specialised service for young people at risk of psychotic disorders. Med. J. Aust. 187:7 Suppl (2007), S43–S46.
52. Yung, A.R., Fusar-Poli, P., Nelson, B., The ultra-high risk approach to define psychosis risk. Curr. Pharm. Des. 18:4 (2012), 346–350.